ArticleActa pharmaceutica Sinica. B2025
A novel dual-targeting strategy of nanobody-driven protein corona modulation for glioma therapy.
Yupei Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it